2023-506289-29-00RecruitingPhase 4
eHealth Based treatment of AdolescenT obesiTy with Low energy diet and sEmaglutide (eBATTLE Obesity)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Sept 2026
Brief summary (registry, in English)
To confirm superiority of once-weekly semaglutide s.c. 2.4 mg versus once-weekly semaglutide s.c. placebo, both as an adjunct to a 52-week blended face-to-face (F2F) and electronic behavioral therapy (eBT) program in treatment-seeking adolescents (12 to <18 years) with obesity on percentage reduction in body weight (% BMI change) [after completion of an initial 8-week blended F2F and electronic LED (eLED)].
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- First submitted
- 8 Aug 2023
- Start date
- 28 Feb 2025
- Lead sponsor
- Vestfold Hospital Trust
- Diseases
- Obesity
- EU CT number
- 2023-506289-29-00
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 220
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for teenagers aged 12 to under 18 who want treatment for obesity and have tried to lose weight on their own before.
- Age
- 12 years to under 18 years
- Sex
- Boys and girls can join.
- Disease stage
- Obesity with BMI of IOTF 35 kg/m2 or more, or BMI of IOTF 30 kg/m2 or more with at least one weight-related health problem, as judged by the treating doctor.
- Earlier treatment
- At least one self-reported unsuccessful diet attempt to lose weight.
Main reasons for not taking part
- Not yet through puberty (Tanner stage 1), self-assessed
- History of type 1 or type 2 diabetes
- Intellectual disability, as judged by the investigator
- Spoken Norwegian that is not good enough, as judged by the investigator
Read by machine on 9 Nov 2026.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants are excluded from the study if any of the following criteria apply: 1. Prepubertal patients (Tanner stage 1), self-assessed, see 8.2.1, table 1. 2. History of diabetes mellitus (type 1 or type 2) as judged by the investigator 3. Intellectual disability as judged by the investigator 4. Sub-optimal level of spoken Norwegian as judged by the investigator
Who the study is looking for
- Participants are eligible to be included in the study only if all of the following criteria apply: 1. Informed consent of parent(s) or legally authorized representative (LAR) of subject and assent of adolescent, as appropriate obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial 2. The trial participant must be above or equal to 12 years and below 18 years of age at the time of signing the informed consent. 3. Treatment seeking male and female adolescent patients with obesity (BMI ≥ IOTF 35 kg/m2) OR BMI ≥ IOTF 30 kg/m2 with at least one weight related comorbidity, risk factor or complication, as considered by the treating physician (44). 4. History of at least one self-reported unsuccessful dietary effort to lose body weight 5. Capable of giving signed informed consent as described in Appendix 3 which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in the study protocol.
Age in the registry: - to 17 years · Sex: All · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Helse Bergen HF | Bergen | Norway | Recruiting |
| Nordlandssykehuset HF | Bodo | Norway | Recruiting |
| Finnmarkssykehuset HF | Hammerfest | Norway | Recruiting |
| Oslo University Hospital HF | Oslo | Norway | Recruiting |
| Vestfold Hospital Trust | Tonsberg | Norway | Recruiting |
| St. Olavs hospital HF | Trondheim | Norway | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.